Recent Finacing
Recent Raise
Apnimed is a privately held late-stage clinical pharmaceutical company developing novel oral therapies for obstructive sleep apnea (OSA).
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Apnimed.
